I Skrzekowska-Baran: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

PDB17 GLYCATED HEMOGLOBIN AS A SURROGATE MARKER FOR THE APPEARANCE AND PROGRESSION OF MACRO VASCULAR COMPLICATIONS IN TYPE 2 DIABETES MELLITUS: SYSTEMATIC REVIEW AND META-ANALYSIS

A Weczorek, A Marcisz, P Rys, I Skrzekowska-Baran, R Plisko, M Wladysiuk

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 76 KB

english, 2010

2

Study types and reliability of Real World Evidence compared with experimental evidence used in Polish reimbursement decision-making processes

Wilk, N., Wierzbicka, N., Skrzekowska-Baran, I., Moćko, P., Tomassy, J., Kloc, K.

Journal:

Year:

2017

Language:

english

File:

PDF, 854 KB

english, 2017

3

Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: A systematic review

P. Rys, O. Pankiewicz, K. Łach, A. Kwaskowski, I. Skrzekowska-Baran, M.T. Malecki

Journal:

Diabetes & Metabolism

Year:

2011

File:

PDF, 542 KB

2011

4

PMC6 META-REGRESSION AS A METHOD OF IDENTIFICATION OF THE CAUSES OF HETEROGENEITY BETWEEN STUDIES ON THE EXAMPLE OF RELATIONSHIP BETWEEN SURROGATES AND CLINICALLY IMPORTANT ENDPOINTS IN TYPE—2 DIABETES MELLITUS

A Marcisz, P Rys, A Wieczorek, R Plisko, M Wladysiuk, I Skrzekowska-Baran

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 86 KB

english, 2009

5

PDB12 GLYCATED HAEMOGLOBIN AS A SURROGATE MARKER FOR THE APPEARANCE AND PROGRESSION OF RETINOPATHY IN TYPE-1 DIABETES MELLITUS: SYSTEMATIC REVIEW AND META-ANALYSIS

A Wieczorek, A Marcisz, P Rys, I Skrzekowska-Baran, R Plisko, M Wladysiuk

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 82 KB

english, 2009

6

PDB40 COST-UTILITY OF BIPHASIC INSULIN ASPART COMPARED WITH PREMIXED HUMAN INSULIN IN TREATMENT OF TYPE-2 DIABETES MELLITUS IN POLAND

D Szmurlo, A Gurda-Duda, P Rys, J Rutkowski, I Skrzekowska-Baran, R Plisko, M Wladysiuk

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 70 KB

english, 2009

7

PDB43 LONG-TERM COST-EFFECTIVENESS OF LIRAGLUTIDE VS. SULPHONYLUREA IN POLAND

M Niewada, W Wrona, M Czech, A Schubert, I Skrzekowska-Baran

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 71 KB

english, 2010

8

PDB15 COMPARATIVE COST-UTILITY ANALYSIS OF LONG-ACTING INSULIN ANALOGUE (INSULIN DETEMIR) AND NPH INSULIN FOR THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES AND THE BUDGET IMPACT ANALYSIS OF INSULIN ANALOGUE REIMBURSEMENT IN POLAND

J Walczak, D Pawlik, A Jasinska, M Garbacka, J Kedzior, T Fundament, I Malczak, W Dardzinski, I Skrzekowska-Baran, M Czech, G Nogas

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 79 KB

english, 2008

9

Costs of diabetes and its complications in Poland

Joanna Leśniowska, Agata Schubert, Michał Wojna, Iwona Skrzekowska-Baran, Marta Fedyna

Journal:

The European Journal of Health Economics

Year:

2014

Language:

english

File:

PDF, 322 KB

english, 2014

10

PDB19 Prevalence of Diabetes Mellitus Among Patients with Vascular Complications in Poland

Fedyna, M., Mucha, A., Kapusniak, A., Bebrysz, M., Rutkowski, J., Schubert, A., Skrzekowska-Baran, I., Rys, P.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

11

PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association: How Much Does Cost-Effective Treatment Cost?

Szmurlo, D., Schubert, A., Kostrzewska, K., Rys, P., Skrzekowska-Baran, I.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 72 KB

english, 2011

12

Information for Readers

Szmurlo, D., Schubert, A., Kostrzewska, K., Rys, P., Skrzekowska-Baran, I.

Journal:

Critical Care Clinics

Year:

2001

Language:

english

File:

PDF, 81 KB

english, 2001

13

PDB32 Cost of Diabetes and its Complications in Poland: Preliminary Results

Lesniowska, J., Schubert,, Skrzekowska-Baran, I.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 61 KB

english, 2011

14

COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND

Kaczor, M.P., Wójcik, R., Pawlik, D., Skrzekowska-Baran, I., Tronczynski, K.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 79 KB

english, 2013

15

Cost-Effectiveness of Injectable Atypical Long-Acting Antipsychotics for Chronic Schizophrenia in Poland

Hemels, M., Einarson, T.R., Zilbershtein, R., Schubert, A., Skrzekowska-Baran, I., Van Impe, K.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 59 KB

english, 2013

16

Cost Effectiveness Evaluation of Canagliflozin in Combination with Metformin and Sulfonylurea in Comparison To Nph Insulin in the Treatment of Type 2 Diabetes Mellitus In Poland

Szmurlo, D., Drzal, R., Plisko, R., Schubert, A., Skrzekowska-Baran, I.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 61 KB

english, 2014

17

Cost Effectiveness Evaluation of Canagliflozin In Combination With Metformin in the Treatment Of Type 2 Diabetes Mellitus In Poland

Szmurlo, D., Drzal, R., Plisko, R., Schubert, A., Skrzekowska-Baran, I.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 62 KB

english, 2014

18

Bortezomib-Based Regimens Used As Induction In Newly Diagnosed Multiple Myeloma (Ndmm) Patients Eligible For Stem Cell Transplantation (Sct)The Cost-Utility Analysis

Mucha, J, Walczak, J, Tronczynski, K, Skrzekowska-Baran, I

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 60 KB

english, 2014

19

Physicians’ Views On Pharma Role In Real World Evidence Generation In Poland

Skrzekowska-Baran, I., Wierzbicka, N., Zmiejko, S.

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 50 KB

english, 2015

20

Predictors of vocational status in schizophrenia patients - Results from the Polish nationwide survey

Kiejna, A., Piotrowski, P., Misiak, B., Adamowski, T., Schubert, A., Skrzekowska-Baran, I., Frydecka, D.

Journal:

International Journal of Social Psychiatry

Year:

2015

Language:

english

File:

PDF, 703 KB

english, 2015

21

Cost Per Qaly as a Potential Hurdle in Accessibility to Innovative Cancer Care in Selected Cee Countries

Chudziak, D, Macioch, T, Jakubczyk, M, Skrzekowska-Baran, I, Palejko-Podrecka, B, Niewada, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 48 KB

english, 2015

22

Treatment Persistence and Discontinuation Risk of Typical Depot and Atypical Long-Acting Antipsychotics in Patients with Schizophrenia in Poland

Wierzbicka, N, Jakubczak, P, Krupa, D, Burski, J, Skrzekowska-Baran, I, Czech, M

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 67 KB

english, 2016

23

Does Real World Evidence Support Conclusions From Experimental Evidence In Decision-Making Processes In Poland?

Wilk, N, Wierzbicka, N, Skrzekowska-Baran, I, Moćko, P, Tomassy, J, Kloc, K

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 62 KB

english, 2016

24

Real World Evidence In Decision-Making Processes On Public Funding Of Drugs In Poland

Wilk, N, Wierzbicka, N, Skrzekowska-Baran, I, Tomassy, J, Kloc, K, Stankowicz, P, Włodek, A

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 62 KB

english, 2016